KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Esperion Therapeutics (ESPR) Shares Issued: 2018-2025

Historic Shares Issued for Esperion Therapeutics (ESPR) over the last 5 years, with Sep 2025 value amounting to $141,000.

  • Esperion Therapeutics' Shares Issued was N/A to $141,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $165.2 million, marking a year-over-year change of. This contributed to the annual value of $90.7 million for FY2024, which is 72.95% up from last year.
  • Esperion Therapeutics' Shares Issued amounted to $141,000 in Q3 2025, which was down 99.84% from $90.7 million recorded in Q1 2024.
  • In the past 5 years, Esperion Therapeutics' Shares Issued registered a high of $204.6 million during Q4 2021, and its lowest value of $141,000 during Q3 2025.
  • Moreover, its 3-year median value for Shares Issued was $52.4 million (2023), whereas its average is $47.7 million.
  • Over the last 5 years, Esperion Therapeutics' Shares Issued had its largest YoY gain of 85,501.26% in 2021, and its largest YoY loss of 95.51% in 2021.
  • Quarterly analysis of 5 years shows Esperion Therapeutics' Shares Issued stood at $204.6 million in 2021, then slumped by 89.25% to $22.0 million in 2022, then spiked by 138.44% to $52.4 million in 2023, then reached $90.7 million in 2024, then reached $141,000 in 2025.
  • Its last three reported values are $141,000 in Q3 2025, $90.7 million for Q1 2024, and $52.4 million during Q4 2023.